Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 23:7:159-68.
doi: 10.2147/DMSO.S62320. eCollection 2014.

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting

Sandra N Ofori  1 , Chioma N Unachukwu  1
Affiliations
Review

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting

Sandra N Ofori et al. Diabetes Metab Syndr Obes. .

Abstract

Diabetes mellitus (DM) is a chronic, progressive metabolic disorder with several complications that affect virtually all the systems in the human body. Type 2 DM (T2DM) is a major risk factor for cardiovascular disease (CVD). The management of T2DM is multifactorial, taking into account other major modifiable risk factors, like obesity, physical inactivity, smoking, blood pressure, and dyslipidemia. A multidisciplinary team is essential to maximize the care of individuals with DM. DM self-management education and patient-centered care are the cornerstones of management in addition to effective lifestyle strategies and pharmacotherapy with individualization of glycemic goals. Robust evidence supports the effectiveness of this approach when implemented. Individuals with DM and their family members usually share a common lifestyle that, not only predisposes the non-DM members to developing DM but also, increases their collective risk for CVD. In treating DM, involvement of the entire family, not only improves the care of the DM individual but also, helps to prevent the risk of developing DM in the family members.

Keywords: cardiovascular disease; multifactorial management.

PubMed Disclaimer

References

    1. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855–862. - PubMed
    1. Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S151–S156. - PMC - PubMed
    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. - PubMed
    1. Adibe MO, Aguwa CN, Ukwe CV. Cost-utility analysis of pharmaceutical care intervention versus usual care in management of Nigerian patients with type 2 diabetes. Value in Health Regional Issues. 2013;2(2):189–198. - PubMed
    1. worldbankorg [homepage on the Internet] World DataBank: World development indicators. The World Bank; 2014. [Accessed. March 26, 2014]. [cited December 26, 2013]. Available from: http://databank.worldbank.org/data/views/variableselection/selectvariabl....

LinkOut - more resources